The Immunoglobulin Receptors and Their Physiological and Pathological Roles in Immunity.
General Material Designation
[Book]
First Statement of Responsibility
Winkel, Jan G.J.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Springer Verlag
Date of Publication, Distribution, etc.
2013
CONTENTS NOTE
Text of Note
Preface. Series Editor's Note. 1. Introduction to the Field; W.H. Fridman. Part A: Physiological Role of Fc Receptors. General Aspects of FcR. 2. Molecular Basis for the Interaction of Fc Receptors with Immunoglobulins; A. Gavin, et al. 3. Fc Receptor Genetics and the Manipulation of Genes in the Study of FcR Biology; T. Takia, J.V. Ravetch. 4. Commentary; R.G. Lynch. FcR & Ig-Transport/Catabolism. 5. The Polymeric Immunoglobulin Receptor; C. Kaetzel, K. Mostov. 6. Multiple Roles of FcRn; N.E. Simister. 7. Commentary: The Polymeric Immunoglobulin Receptor and the Brambell Receptor: Non-Hematopoietic FcRs, with Much to Compare; R.P. Junghans. FcR & Cell Activation. 8. Signals Initiated by the High Affinity FcR for IgE; O.H. Choi, P.G. Holbrook. 9. Phagocyte Fc Receptors for IgG; S.E. McKenzie, et al. 10. Human IgA Fc Receptors (FcalphaR); H.C. Morton, et al. 11. Platelet Fc-Receptors for IgG and IgE; A. Greinacher. 12. Polymorphisms of FcgammaRIIIa on NK Cells and Macrophages; H.R. Koene, et al. 13. Cooperation between IgG FC Receptors and Complement Receptors in Host Defense; E.J. Brown. 14. Commentary; H. Metzger. FcR & Immunoregulation. 15. FcgammaR and IgG-Mediated Negative Regulation of Immune Responses; M. Daeron, B. Heyman. 16. FcgammaR on T Cells; M. Sandor, R.G. Lynch. 17. Role of IgG and IgE FcR in Antigen Presentation; P.M. Guyre, J.K. O'Shea. 18. Structure and Function of CD23; D.H. Conrad. 19. Commentary onFcR Regulation of Development and Function of the Immune System; J.C. Cambier. Part B: Clinical Aspects of Fc Receptors. 20. The Role and Use of Recombinant Receptors in the Investigation and Control of Antibody-Induced Inflammation; M.S. Powell, P.M. Hogarth. 21. FcR and Autoimmunity; R. Repp, J.G.J. Van de Winkel. 22. Heparin Induced Thrombocytopenia as a Model for Fc RII Mediated Disease; R. Baker, B. Dale. 23. Fc Receptor Polymorphisms Clinical Aspects; J.E. Salmon, R. Kimberly. 24. Soluble Fc R, A Biological Perspective; C. Sautes, et al. 25. Fc E-Directed Immunotherapies; C.A. Guyre, et al. 26. Commentary: The rewards of Conversion of FcRISM; W. Boyle. 27. Historical/Future Perspectives; P.M. Hogarth, J.G.J. Van de Winkel. Index.